{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:47:07Z","timestamp":1791809227456,"version":"4.3.4"},"reference-count":112,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroimaging Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.nic.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:19:04Z","timestamp":1784546344000},"page":"771-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging of Spinal Cord Inflammatory Disorders"],"prefix":"10.1016","volume":"36","author":[{"given":"Monica","family":"Margoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/CON.0000000000000900","article-title":"Myelitis and other autoimmune myelopathies","volume":"27","author":"Lopez Chiriboga","year":"2021","journal-title":"Continuum"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.nic.2026.06.005_bib4","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis","volume":"73","author":"Fang","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nic.2026.06.005_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/B978-0-444-63432-0.00019-0","article-title":"Autoimmune myelopathies","volume":"133","author":"Flanagan","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"16","key":"10.1016\/j.nic.2026.06.005_bib6","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/WNL.0000000000003235","article-title":"Progressive solitary sclerosis: gradual motor impairment from a single CNS demyelinating lesion","volume":"87","author":"Keegan","year":"2016","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.nic.2026.06.005_bib7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib8","first-page":"195","article-title":"Paraneoplastic necrotizing myelopathy in a patient with newly diagnosed diffuse large B cell lymphoma","volume":"2","author":"Lee","year":"2011","journal-title":"World J Oncol"},{"issue":"24","key":"10.1016\/j.nic.2026.06.005_bib9","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1212\/WNL.0b013e31821f468f","article-title":"Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues","volume":"76","author":"Flanagan","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.24881","article-title":"Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients","volume":"81","author":"Flanagan","year":"2017","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib11","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000722","article-title":"Clinical and MRI phenotypes of sarcoidosis-associated myelopathy","volume":"7","author":"Murphy","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.nic.2026.06.005_bib12","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3389\/fimmu.2019.00726","article-title":"The cerebrospinal fluid in multiple sclerosis","volume":"10","author":"Deisenhammer","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib13","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s12974-020-01825-1","article-title":"Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients","volume":"17","author":"Jarius","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","article-title":"Clinical, radiologic, and prognostic features of myelitis associated with myelin oligodendrocyte glycoprotein autoantibody","volume":"76","author":"Dubey","year":"2019","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.nic.2026.06.005_bib16","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001084","article-title":"Neurosarcoidosis: pathophysiology, diagnosis, and treatment","volume":"8","author":"Bradshaw","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70489","article-title":"Investigation of prognostic factors in patients with autoimmune glial fibrillary acidic protein astrocytopathy","volume":"33","author":"Kimura","year":"2026","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000967","article-title":"Longitudinally extensive myelitis associated with immune checkpoint inhibitors","volume":"8","author":"Picca","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"10","key":"10.1016\/j.nic.2026.06.005_bib19","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S1474-4422(25)00304-7","article-title":"2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosis","volume":"24","author":"Barkhof","year":"2025","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.nic.2026.06.005_bib20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1161\/01.STR.0000018009.83713.06","article-title":"Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients","volume":"33","author":"Van Dijk","year":"2002","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.nic.2026.06.005_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1212\/WNL.0000000000006857","article-title":"Ventral-subpial enhancement in spinal cord sarcoidosis: a braid-like sign","volume":"92","author":"Boban","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1212\/WNL.0b013e318297ef07","article-title":"Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient","volume":"81","author":"Asgari","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.nic.2024.03.001","article-title":"Diagnostic criteria for multiple sclerosis, neuromyelitis optica spectrum disorders, and myelin oligodendrocyte glycoprotein-immunoglobulin G-associated disease","volume":"34","author":"Filippi","year":"2024","journal-title":"Neuroimaging Clin N Am"},{"issue":"11","key":"10.1016\/j.nic.2026.06.005_bib24","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1212\/WNL.0000000000001367","article-title":"MRI characteristics of neuromyelitis optica spectrum disorder: an international update","volume":"84","author":"Kim","year":"2015","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.nic.2026.06.005_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1474-4422(23)00148-5","article-title":"Differential diagnosis of suspected multiple sclerosis: an updated consensus approach","volume":"22","author":"Solomon","year":"2023","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1474-4422(18)30460-5","article-title":"Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"18","author":"Ciccarelli","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nic.2026.06.005_bib27","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-12-823912-4.00017-7","article-title":"Paraneoplastic\/autoimmune myelopathies","volume":"200","author":"Montalvo","year":"2024","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.nic.2026.06.005_bib28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.msard.2016.04.005","article-title":"Specific MRI findings help distinguish acute transverse myelitis of neuromyelitis optica from spinal cord infarction","volume":"9","author":"Kister","year":"2016","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1016\/j.nic.2026.06.005_bib29","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.0000000000002992","article-title":"Central canal enhancement and the trident sign in spinal cord sarcoidosis","volume":"87","author":"Zalewski","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.25004","article-title":"Myelopathy in behcet\u2019s disease: the bagel sign","volume":"82","author":"Uygunoglu","year":"2017","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.nic.2026.06.005_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae395","article-title":"Spinal cord evaluation in multiple sclerosis: clinical and radiological associations, present and future","volume":"6","author":"Keegan","year":"2024","journal-title":"Brain Commun"},{"issue":"9","key":"10.1016\/j.nic.2026.06.005_bib32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1474-4422(03)00504-0","article-title":"Spinal-cord MRI in multiple sclerosis","volume":"2","author":"Lycklama","year":"2003","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1212\/WNL.62.2.226","article-title":"Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination","volume":"62","author":"Bot","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nic.2026.06.005_bib34","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1177\/1352458512442754","article-title":"Biplanar MRI for the assessment of the spinal cord in multiple sclerosis","volume":"18","author":"Weier","year":"2012","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib35","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(14)70294-7","article-title":"MRI monitoring of pathological changes in the spinal cord in patients with multiple sclerosis","volume":"14","author":"Gass","year":"2015","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.nic.2026.06.005_bib36","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1177\/1352458515604905","article-title":"Grey matter involvement by focal cervical spinal cord lesions is associated with progressive multiple sclerosis","volume":"22","author":"Kearney","year":"2016","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/brain\/awy352","article-title":"Spatial distribution of multiple sclerosis lesions in the cervical spinal cord","volume":"142","author":"Eden","year":"2019","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.nic.2026.06.005_bib38","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3174\/ajnr.A3637","article-title":"Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3T","volume":"34","author":"Nair","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib39","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1148\/radiol.2018172311","article-title":"Cervical cord T1-weighted hypointense lesions at MR imaging in multiple sclerosis: relationship to cord atrophy and disability","volume":"288","author":"Valsasina","year":"2018","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1212\/01.wnl.0000341324.55937.d9","article-title":"Open-ring peripherally enhancing lesion of the cervical spine","volume":"72","author":"Pyle","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.nic.2026.06.005_bib41","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneurol.2010.271","article-title":"Spinal cord ring enhancement in multiple sclerosis","volume":"67","author":"Klawiter","year":"2010","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib42","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00415-025-12979-4","article-title":"Cervical spinal cord gray matter damage predicts disability worsening in multiple sclerosis: a longitudinal study","volume":"272","author":"Azzimonti","year":"2025","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/jnnp-2022-329854","article-title":"Spinal cord lesions and brain grey matter atrophy independently predict clinical worsening in definite multiple sclerosis: a 5-year, multicentre study","volume":"94","author":"Rocca","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib44","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1148\/radiol.2020192664","article-title":"Spinal cord atrophy in neuromyelitis optica spectrum disorders is spatially related to cord lesions and disability","volume":"297","author":"Cacciaguerra","year":"2020","journal-title":"Radiology"},{"key":"10.1016\/j.nic.2026.06.005_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120687","article-title":"Marked central canal T2-hyperintensity in MOGAD myelitis and comparison to NMOSD and MS","volume":"450","author":"Webb","year":"2023","journal-title":"J Neurol Sci"},{"issue":"14","key":"10.1016\/j.nic.2026.06.005_bib46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1212\/WNL.0000000000010662","article-title":"Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease","volume":"95","author":"Mastrangelo","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.25146","article-title":"Central vein sign differentiates multiple sclerosis from central nervous system inflammatory vasculopathies","volume":"83","author":"Maggi","year":"2018","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib48","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/13524585211007086","article-title":"Central vein sign and other radiographic features distinguishing myelin oligodendrocyte glycoprotein antibody disease from multiple sclerosis and aquaporin-4 antibody-positive neuromyelitis optica","volume":"28","author":"Ciotti","year":"2022","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.nic.2026.06.005_bib49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/01.wnl.0000343001.36493.ae","article-title":"Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders","volume":"72","author":"Magana","year":"2009","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib50","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jamaneurol.2014.2137","article-title":"Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders","volume":"72","author":"Flanagan","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nic.2026.06.005_bib51","article-title":"Short segment myelitis as the initial and only manifestation of aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorders","volume":"13","author":"Fang","year":"2020","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.nic.2026.06.005_bib52","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2015.11.040","article-title":"Linear lesions may assist early diagnosis of neuromyelitis optica and longitudinally extensive transverse myelitis, two subtypes of NMOSD","volume":"360","author":"Cai","year":"2016","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib53","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/ana.26279","article-title":"Investigating the immunopathogenic mechanisms underlying MOGAD","volume":"91","author":"McCombe","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nic.2026.06.005_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.101965","article-title":"Prodromal headache in MOG-antibody positive optic neuritis","volume":"40","author":"Asseyer","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"7","key":"10.1016\/j.nic.2026.06.005_bib55","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/archneurol.2011.127","article-title":"A benign form of neuromyelitis optica: does it exist?","volume":"68","author":"Collongues","year":"2011","journal-title":"Arch Neurol"},{"issue":"14","key":"10.1016\/j.nic.2026.06.005_bib56","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1177\/1352458518815596","article-title":"Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity","volume":"25","author":"Chien","year":"2019","journal-title":"Mult Scler"},{"issue":"10","key":"10.1016\/j.nic.2026.06.005_bib57","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12732","article-title":"Comparison of clinical outcomes of transverse myelitis among adults with myelin oligodendrocyte glycoprotein antibody vs Aquaporin-4 antibody disease","volume":"2","author":"Mariano","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/1352458520907900","article-title":"Frequency and characteristics of MRI-Negative myelitis associated with MOG autoantibodies","volume":"27","author":"Sechi","year":"2021","journal-title":"Mult Scler"},{"issue":"8","key":"10.1016\/j.nic.2026.06.005_bib59","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/1352458519849511","article-title":"Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: a retrospective multicentric study","volume":"26","author":"Ciron","year":"2020","journal-title":"Mult Scler"},{"issue":"10271","key":"10.1016\/j.nic.2026.06.005_bib60","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0140-6736(20)32723-9","article-title":"Acute flaccid myelitis: cause, diagnosis, and management","volume":"397","author":"Murphy","year":"2021","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.nic.2026.06.005_bib61","first-page":"1986","article-title":"West nile virus meningoencephalitis: MR imaging findings","volume":"26","author":"Petropoulou","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"10.1016\/j.nic.2026.06.005_bib62","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Deneve","year":"2019","journal-title":"J Neuroradiol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib63","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200449","article-title":"Spinal cord leptomeningeal enhancement as a marker of extensive spinal cord involvement in children with MOGAD","volume":"13","author":"Bartiromo","year":"2026","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib64","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ene.14089","article-title":"Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients","volume":"27","author":"Shor","year":"2020","journal-title":"Eur J Neurol"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib65","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458515591071","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: clinical and prognostic implications","volume":"22","author":"Cobo-Calvo","year":"2016","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib67","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/jnnp-2018-318004","article-title":"Glial fibrillary acidic protein IgG related myelitis: characterisation and comparison with aquaporin-4-IgG myelitis","volume":"90","author":"Sechi","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib68","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000046689","article-title":"Glial fibrillary acidic protein antibody-associated astrocytopathy presents isolated spinal cord enhancement: a case report","volume":"105","author":"Wang","year":"2026","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib69","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s10072-022-05937-9","article-title":"Typical linear radial periventricular enhancement in a patient with glial fibrillary acidic protein (GFAP) astrocytopathy","volume":"43","author":"Lin","year":"2022","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.nic.2026.06.005_bib70","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1212\/WNL.0000000000013087","article-title":"Glial fibrillary acidic protein autoimmunity: a French cohort study","volume":"98","author":"Gravier-Dumonceau","year":"2022","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib71","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/ene.13531","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study","volume":"25","author":"Long","year":"2018","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib72","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1756285609349521","article-title":"Progress in the management of paraneoplastic neurological disorders","volume":"3","author":"Sadeghian","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib73","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1474-4422(23)00369-1","article-title":"Neurological adverse events of immune checkpoint inhibitors and the development of paraneoplastic neurological syndromes","volume":"23","author":"Farina","year":"2024","journal-title":"Lancet Neurol"},{"issue":"16","key":"10.1016\/j.nic.2026.06.005_bib74","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0000000000011795","article-title":"Neurologic adverse events of immune checkpoint inhibitors: a systematic review","volume":"96","author":"Marini","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.nic.2026.06.005_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.642800","article-title":"Paraneoplastic neurological syndromes and beyond emerging with the introduction of immune checkpoint inhibitor cancer immunotherapy","volume":"12","author":"Valencia-Sanchez","year":"2021","journal-title":"Front Neurol"},{"issue":"9","key":"10.1016\/j.nic.2026.06.005_bib76","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.mayocp.2019.02.003","article-title":"Neurologic autoimmunity in the era of checkpoint inhibitor cancer immunotherapy","volume":"94","author":"Zekeridou","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib77","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1007\/s13311-022-01184-0","article-title":"Paraneoplastic autoimmune neurological syndromes and the role of immune checkpoint inhibitors","volume":"19","author":"Duong","year":"2022","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib78","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13244-025-01999-3","article-title":"Neuroimaging features of immune-related adverse events due to immune checkpoint inhibitor therapy","volume":"16","author":"Lasocki","year":"2025","journal-title":"Insights Imaging"},{"key":"10.1016\/j.nic.2026.06.005_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578816","article-title":"Neurological adverse events of immune checkpoint inhibitors: a practical guide to diagnosis with a focus on neuroimaging findings","volume":"410","author":"Rossi","year":"2026","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nic.2026.06.005_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1130313","article-title":"Case series: immune checkpoint inhibitor-induced transverse myelitis","volume":"14","author":"Chatterton","year":"2023","journal-title":"Front Neurol"},{"issue":"17","key":"10.1016\/j.nic.2026.06.005_bib81","doi-asserted-by":"crossref","first-page":"e2442","DOI":"10.1212\/WNL.0000000000010632","article-title":"Neurologic autoimmunity and immune checkpoint inhibitors: autoantibody profiles and outcomes","volume":"95","author":"Sechi","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib82","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamaneurol.2019.4379","article-title":"CRMP5-IgG-Associated paraneoplastic myelopathy with PD-L1 inhibitor therapy","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib83","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1212\/CON.0000000000000926","article-title":"Neuroimaging of spinal cord and Cauda Equina disorders","volume":"27","author":"Diehn","year":"2021","journal-title":"Continuum"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib84","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.24582","article-title":"Discriminating long myelitis of neuromyelitis optica from sarcoidosis","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib85","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/WNL.43.2.333","article-title":"Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics","volume":"43","author":"Junger","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib86","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ncl.2009.09.004","article-title":"Neurologic manifestations of systemic lupus erythematosus in children and adults","volume":"28","author":"Muscal","year":"2010","journal-title":"Neurol Clin"},{"issue":"5","key":"10.1016\/j.nic.2026.06.005_bib87","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051482","article-title":"Clinical, radiological, and laboratory features of spinal cord involvement in primary sjogren\u2019s syndrome","volume":"9","author":"Butryn","year":"2020","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib88","doi-asserted-by":"crossref","first-page":"35","DOI":"10.31083\/j.jin2302035","article-title":"Systemic connective tissue disease and neuromyelitis optica spectrum disorder coexistence: a systematic review and meta-analysis","volume":"23","author":"Esposito","year":"2024","journal-title":"J Integr Neurosci"},{"key":"10.1016\/j.nic.2026.06.005_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.577051","article-title":"Very late-onset recurrent myelitis in a patient diagnosed with antiphospholipid syndrome: a puzzle of autoimmunity","volume":"337","author":"Margoni","year":"2019","journal-title":"J Neuroimmunol"},{"issue":"7","key":"10.1016\/j.nic.2026.06.005_bib90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11910-018-0843-5","article-title":"Behcet\u2019s syndrome and nervous system involvement","volume":"18","author":"Uygunoglu","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"10.1016\/j.nic.2026.06.005_bib91","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archneur.63.8.1113","article-title":"Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients","volume":"63","author":"Novy","year":"2006","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.nic.2026.06.005_bib92","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/CPJ.0000000000001036","article-title":"Utility of MRI enhancement pattern in myelopathies with longitudinally extensive T2 lesions","volume":"11","author":"Mustafa","year":"2021","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib93","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/practneurol-2017-001845","article-title":"A practical approach to the diagnosis of spinal cord lesions","volume":"18","author":"Mariano","year":"2018","journal-title":"Pract Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib94","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/CON.0000000000001376","article-title":"Metabolic and toxic myelopathies","volume":"30","author":"Holroyd","year":"2024","journal-title":"Continuum"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib95","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00415-021-10748-7","article-title":"Neurological consequences of recreational nitrous oxide abuse during SARS-CoV-2 pandemic","volume":"269","author":"Vollhardt","year":"2022","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib96","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.24184","article-title":"Specific pattern of gadolinium enhancement in spondylotic myelopathy","volume":"76","author":"Flanagan","year":"2014","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.nic.2026.06.005_bib97","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1148\/radiology.197.3.7480734","article-title":"Spinal cord ependymomas: MR imaging features","volume":"197","author":"Fine","year":"1995","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib98","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s00062-020-00909-y","article-title":"The central dot sign : a specific post-gadolinium enhancement feature of intramedullary spinal cord metastases","volume":"31","author":"Madhavan","year":"2021","journal-title":"Clin Neuroradiol"},{"issue":"5","key":"10.1016\/j.nic.2026.06.005_bib99","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.sult.2023.03.015","article-title":"Infectious myelitis","volume":"44","author":"Miyoshi","year":"2023","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.nic.2026.06.005_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01104","article-title":"Acute transverse myelitis in west nile virus, a rare neurological presentation","volume":"24","author":"Jani","year":"2021","journal-title":"IDCases"},{"key":"10.1016\/j.nic.2026.06.005_bib101","article-title":"HIV-associated vacuolar myelopathy: a rare initial presentation of HIV","volume":"8","author":"Rezaie","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"issue":"9","key":"10.1016\/j.nic.2026.06.005_bib102","doi-asserted-by":"crossref","first-page":"5615","DOI":"10.1007\/s10072-022-06221-6","article-title":"Tuberculous myelitis: a prospective follow-up study","volume":"43","author":"Khan","year":"2022","journal-title":"Neurol Sci"},{"key":"10.1016\/j.nic.2026.06.005_bib103","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.2147\/NDT.S492208","article-title":"Clinical insights into neurosyphilis patients with leptomeningeal enhancement of spinal cord","volume":"20","author":"Zhang","year":"2024","journal-title":"Neuropsychiatric Dis Treat"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s13760-025-02833-9","article-title":"Insights into diagnostics and management of spinal neuroschistosomiasis: A scoping review of 230 cases of a neglected disease","volume":"126","author":"Ali","year":"2026","journal-title":"Acta Neurol Belg"},{"issue":"12","key":"10.1016\/j.nic.2026.06.005_bib105","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1001\/archneur.63.12.1686","article-title":"Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review","volume":"63","author":"Langer-Gould","year":"2006","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib106","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40478-017-0495-8","article-title":"Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease","volume":"5","author":"Jurynczyk","year":"2017","journal-title":"Acta Neuropathol Commun"},{"issue":"2","key":"10.1016\/j.nic.2026.06.005_bib107","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.23909","article-title":"Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica","volume":"74","author":"Ciccarelli","year":"2013","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.0b013e31827b1a67","article-title":"Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis","volume":"80","author":"Sombekke","year":"2013","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nic.2026.06.005_bib109","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3174\/ajnr.A3342","article-title":"(1)H-MR spectroscopy in the human spinal cord","volume":"34","author":"Hock","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"10.1016\/j.nic.2026.06.005_bib110","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/acn3.70046","article-title":"Spinal cord abnormalities in early pediatric multiple sclerosis","volume":"12","author":"Margoni","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.nic.2026.06.005_bib111","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/brain\/awaa347","article-title":"Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis","volume":"144","author":"Mariano","year":"2021","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nic.2026.06.005_bib112","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.semnuclmed.2024.07.002","article-title":"Toward functional PET imaging of the spinal cord","volume":"55","author":"Courault","year":"2025","journal-title":"Semin Nucl Med"}],"container-title":["Neuroimaging Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514926000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1052514926000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:08:44Z","timestamp":1791806924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1052514926000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":112,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1052514926000535"],"URL":"https:\/\/doi.org\/10.1016\/j.nic.2026.06.005","relation":{},"ISSN":["1052-5149"],"issn-type":[{"value":"1052-5149","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging of Spinal Cord Inflammatory Disorders","name":"articletitle","label":"Article Title"},{"value":"Neuroimaging Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nic.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}